Gangagen Biotechnologies Overview
- Year Founded
-
2000
- Status
-
Private
- Employees
-
57
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
Gangagen Biotechnologies General Information
Description
Developer of novel engineering treatments designed to prevent bacterial infections that are resistant to antibiotics. The company's treatment is a recombinant protein that binds to and kills Staphylococcus, including methicillin-resistant strains of S.aureus, offering an innovative approach to treat infections caused by multidrug-resistant Klebsiella pneumonia, including the carbapenem-resistant and extended-spectrum ß-lactamase expressing strains of particular clinical concern, enabling clinicians to combat life-threatening infections such as pneumonia and neonatal sepsis.
Contact Information
Website
www.gangagen.comCorporate Office
- Number 12, 5th Cross, Raghavendra Layout
- Opposite MEI Limited, Tumkur Road, Yeshwanthpur
- Bangalore, Karnataka 560022
- India
Corporate Office
- Number 12, 5th Cross, Raghavendra Layout
- Opposite MEI Limited, Tumkur Road, Yeshwanthpur
- Bangalore, Karnataka 560022
- India
Gangagen Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 9. Grant | 10-Aug-2023 | Completed | Clinical Trials - Phase 2 | |||
| 8. Grant | 05-Oct-2020 | Completed | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC (Series E) | 07-Oct-2008 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC (Series D) | Completed | Pre-Clinical Trials | ||||
| 5. Later Stage VC | 06-Dec-2006 | Completed | Pre-Clinical Trials | |||
| 4. Later Stage VC (Series C) | 12-Jan-2006 | Completed | Pre-Clinical Trials | |||
| 3. Later Stage VC | 28-Nov-2005 | Completed | Startup | |||
| 2. Early Stage VC (Series B) | 15-May-2003 | $1.91M | $1.91M | Completed | Startup | |
| 1. Early Stage VC (Series A) | Completed | Startup |
Gangagen Biotechnologies Comparisons
Industry
Financing
Details
Gangagen Biotechnologies Competitors (48)
One of Gangagen Biotechnologies’s 48 competitors is NovaBiotics, a Venture Capital-Backed company based in Aberdeen, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NovaBiotics | Venture Capital-Backed | Aberdeen, United Kingdom | ||||
| Venatorx Pharmaceuticals | Venture Capital-Backed | Malvern, PA | ||||
| Eligo Bioscience | Venture Capital-Backed | Paris, France | ||||
| Noveome Biotherapeutics | Venture Capital-Backed | Pittsburgh, PA | ||||
| Enterome | Venture Capital-Backed | Paris, France |
Gangagen Biotechnologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Gangagen Biotechnologies Patents
Gangagen Biotechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025210679-A1 | A composition for treating klebsiella infections and methods thereof | Pending | 03-Apr-2024 | ||
| CA-3225734-A1 | Chimeric klebicins | Pending | 12-Jul-2021 | ||
| EP-4370533-A2 | Chimeric klebicins | Pending | 12-Jul-2021 | ||
| EP-4370533-A4 | Chimeric klebicins | Pending | 12-Jul-2021 | ||
| US-12606598-B2 | Chimeric klebicins | Active | 12-Jul-2021 | C07K14/26 |
Gangagen Biotechnologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Gangagen Biotechnologies Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CARB-X | University | |||
| ATEL Capital Group | Asset Manager | Minority | ||
| Otsuka Pharmaceutical | Corporation | Minority |
Gangagen Biotechnologies FAQs
-
When was Gangagen Biotechnologies founded?
Gangagen Biotechnologies was founded in 2000.
-
Where is Gangagen Biotechnologies headquartered?
Gangagen Biotechnologies is headquartered in Bangalore, India.
-
What is the size of Gangagen Biotechnologies?
Gangagen Biotechnologies has 57 total employees.
-
What industry is Gangagen Biotechnologies in?
Gangagen Biotechnologies’s primary industry is Biotechnology.
-
Is Gangagen Biotechnologies a private or public company?
Gangagen Biotechnologies is a Private company.
-
What is Gangagen Biotechnologies’s current revenue?
The current revenue for Gangagen Biotechnologies is .
-
How much funding has Gangagen Biotechnologies raised over time?
Gangagen Biotechnologies has raised $14.1M.
-
Who are Gangagen Biotechnologies’s investors?
CARB-X, ATEL Capital Group, and Otsuka Pharmaceutical have invested in Gangagen Biotechnologies.
-
Who are Gangagen Biotechnologies’s competitors?
NovaBiotics, Venatorx Pharmaceuticals, Eligo Bioscience, Noveome Biotherapeutics, and Enterome are some of the 48 competitors of Gangagen Biotechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
